Powder: -20℃ for 3 years | In solvent: -80℃ for 1 year
货源
新品
图文详情
SKLB1028 is a new type of oral multikinase inhibitor of EGFR, FLT3, and Abl. It shows excellent activity in FLT3-driven AML models and considerable potency in CML models containing Abl mutants.